
- Volume 0 0
REPORT FINDS PART D EXPLANATIONS CONFUSING
Seniors confusedabout theiroptions underthe new MedicarePart D drugbenefit may notbe getting muchhelp from theexplanations putout by the government'sCenters for Medicare &Medicaid Services (CMS), investigatorswith the congressional GovernmentAccountability Office (GAO) charged.
In a new report on the quality ofinformation put out by CMS to explainPart D, GAO researchers concluded thatthe agency may be leaving manyMedicare recipients confused aboutthe program. The CMS documents preparedto explain the program to seniors"used too much technical jargon andoften did not define difficult terms, suchas formulary," said the GAO officials.
Moreover, whereas 40% of thenation's seniors read at or below the5th-grade level, "the reading levels ofthese [Part D] documents ranged from7th grade to postcollege," the reportsaid. Although the literature producedby CMS to explain the Part D benefitwas "largely complete and accurate," the information "lacked clarity," theGAO investigators said.
Articles in this issue
over 19 years ago
can you READ these Rxs?over 19 years ago
case STUDIESover 19 years ago
Compounding HOTLINEover 19 years ago
RESPy AWARDover 19 years ago
Compounding for Prenatal Patientsover 19 years ago
Prescription Monitoring Programsover 19 years ago
Patients Sue the US Government to Allow Drugs from Canadaover 19 years ago
FMEA Can Help Prevent Errorsover 19 years ago
On-line Health Care: Identifying Quality InformationNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.